Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$170M Buy
+7,775,543
New +$209M 0.03% 425

Other funds holding APMD

Ameriprise's APMD Position: Q3 2026 in Review

Ameriprise opened a new position in Apnimed (APMD) in Q3 2026: 7,775,543 shares worth $170M. The stake represents 0.03% of the portfolio and ranks #425 among its holdings.

71 funds tracked by Wall St. Rank hold APMD as of Q3 2026.

  • Ameriprise held 7,775,543 shares of Apnimed worth $170M as of Q3 2026.
  • Apnimed was a new Ameriprise position in Q3 2026.
  • Apnimed made up 0.03% of Ameriprise's portfolio in Q3 2026, its #425 holding.
  • 71 funds tracked by Wall St. Rank held Apnimed as of Q3 2026.

Based on Ameriprise's 13F filing for Q3 2026, filed 16 Nov 2026.